Involvement of dopaminergic neuronal cystatin C in neuronal injury-induced microglial activation and neurotoxicity

Journal of Neurochemistry

Volumn 122, Issue 4, 2012, Pages 752-763

  Dutta, Garima ^a   Barber, David S ^b   Zhang, Ping ^a   Doperalski, Nicholas J ^b   Liu, Bin ^a  

^a UNIVERSITY OF FLORIDA HEALTH   (United States)

^b University of Florida   (United States)

Author keywords

Caspase 3; cytokine; dopamine neuron; microglia; nitric oxide; reactive oxygen species

Indexed keywords

CYSTATIN C; INDUCIBLE NITRIC OXIDE SYNTHASE;

ANIMAL CELL; ARTICLE; CELL ACTIVATION; CELL COUNT; CELL VIABILITY; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; DEGLYCOSYLATION; DOPAMINERGIC NERVE CELL; GLYCOSYLATION; IMMUNOBLOTTING; MICROGLIA; NERVE DEGENERATION; NEUROTOXICITY; NONHUMAN; PRIORITY JOURNAL; PROTEIN DETERMINATION; PROTEIN FUNCTION; PROTEOMICS; RAT; UPREGULATION;

ANIMALS; BLOTTING, WESTERN; CELL SURVIVAL; CELLS, CULTURED; COLORING AGENTS; CULTURE MEDIA, CONDITIONED; CYSTATIN C; CYTOKINES; DIELDRIN; DOPAMINERGIC NEURONS; FLUORESCENT ANTIBODY TECHNIQUE; GLYCOSYLATION; INFLAMMATION; MACROPHAGE ACTIVATION; MICROGLIA; MPTP POISONING; MUTAGENS; NEURONS; NEUROTOXICITY SYNDROMES; NITRITES; PROTEOMICS; RATS; REACTIVE OXYGEN SPECIES; TETRAZOLIUM SALTS; THIAZOLES;

RATTUS;

EID: 84864144615     PISSN: 00223042     EISSN: 14714159     Source Type: Journal    
DOI: 10.1111/j.1471-4159.2012.07826.x     Document Type: Article

References (63)

1. Abrahamson M., Grubb A., Olafsson I., and, Lundwall A., (1987) Molecular cloning and sequence analysis of cDNA coding for the precursor of the human cysteine proteinase inhibitor cystatin C. FEBS Lett. 216, 229-233.
2. Barber D. S., Stevens S., and, LoPachin R. M., (2007) Proteomic analysis of rat striatal synaptosomes during acrylamide intoxication at a low dose rate. Toxicol. Sci. 100, 156-167.
3. Barrett A. J., (1986) The cystatins: a diverse superfamily of cysteine peptidase inhibitors. Biomed. Biochim. Acta 45, 1363-1374.
4. Bell-Temin H., Barber D. S., Zhang P., Liu B., and, Stevens Jr S. M., (2012) Proteomic analysis of rat microglia establishes a high-confidence reference data set of over 3000 proteins. Proteomics 12, 246-250.
5. Betarbet R., Sherer T. B., MacKenzie G., Garcia-Osuna M., Panov A. V., and, Greenamyre J. T., (2000) Chronic systemic pesticide exposure reproduces features of Parkinson's disease. Nat. Neurosci. 3, 1301-1306.
6. Bhat N. R., and, Feinstein D. L., (2006) NO and glial cell biology. Antioxid. Redox Signal. 8, 869-872.
7. Bonomini F., Foglio E., Rodella L. F., and, Rezzani R., (2010) Clinical biomarkers in kidney diseases. Front. Biosci. (Schol. Ed.) 2, 591-615.
8. Cheepsunthorn P., Radov L., Menzies S., Reid J., and, Connor J. R., (2001) Characterization of a novel brain-derived microglial cell line isolated from neonatal rat brain. Glia 35, 53-62.
9. Chesselet M. F., and, Richter F., (2011) Modelling of Parkinson's disease in mice. Lancet Neurol. 10, 1108-1118.
10. Clarkson E. D., Rosa F. G., Edwards-Prasad J., Weiland D. A., Witta S. E., Freed C. R., and, Prasad K. N., (1998) Improvement of neurological deficits in 6-hydroxydopamine-lesioned rats after transplantation with allogeneic simian virus 40 large tumor antigen gene-induced immortalized dopamine cells. Proc. Natl Acad. Sci. USA 95, 1265-1270.
11. Dahl A., Eriksson P. S., Davidsson P., Persson A. I., Ekman R., and, Westman-Brinkmalm A., (2004) Demonstration of multiple novel glycoforms of the stem cell survival factor CCg. J. Neurosci. Res. 77, 9-14.
12. Deng A., Irizarry M. C., Nitsch R. M., Growdon J. H., and, Rebeck G. W., (2001) Elevation of cystatin C in susceptible neurons in Alzheimer's disease. Am. J. Pathol. 159, 1061-1068.
13. Duke D. C., Moran L. B., Pearce R. K., and, Graeber M. B., (2007) The medial and lateral substantia nigra in Parkinson's disease: mRNA profiles associated with higher brain tissue vulnerability. Neurogenetics 8, 83-94.
14. Dutta G., Zhang P., and, Liu B., (2008) The lipopolysaccharide Parkinson's disease animal model: mechanistic studies and drug discovery. Fundam. Clin. Pharmacol. 22, 453-464.
15. Elbaz A., Jacqueline C., Paul J. R., FrÈdÈric M., Jean-Philippe G., Bernard D., Annick A., and, Christophe T., (2009) Professional exposure to pesticides and Parkinson disease. Ann. Neurol. 66, 494-504.
16. Frendeus K. H., Wallin H., Janciauskiene S., and, Abrahamson M., (2009) Macrophage responses to interferon-gamma are dependent on cystatin C levels. Int. J. Biochem. Cell Biol. 41, 2262-2269.
17. Gao H. M., Jiang J., Wilson B., Zhang W., Hong J. S., and, Liu B., (2002) Microglial activation-mediated delayed and progressive degeneration of rat nigral dopaminergic neurons: relevance to Parkinson's disease. J. Neurochem. 81, 1285-1297.
18. Hancock D., Martin E., Mayhew G., Stajich J., Jewett R., Stacy M., Scott B., Vance J., and, Scott W., (2008) Pesticide exposure and risk of Parkinson's disease: a family-based case-control study. BMC Neurol. 8, 6.
19. Hatcher J. M., Richardson J. R., Guillot T. S., McCormack A. L., Di Monte D. A., Jones D. P., Pennell K. D., and, Miller G. W., (2007) Dieldrin exposure induces oxidative damage in the mouse nigrostriatal dopamine system. Exp. Neurol. 204 619-630.
20. Jenner P,. (2003) Oxidative stress in Parkinson's disease. Ann. Neurol., 53 Suppl 3 S26-36; discussion S36-28.
21. Kaeser S. A., Herzig M. C., Coomaraswamy J., et al. (2007) Cystatin C modulates cerebral beta-amyloidosis. Nat. Genet., 39 1437-1439.
22. Kamel F., Engel L. S., Gladen B. C., Hoppin J. A., Alavanja M. C., and, Sandler D. P., (2007a) Neurologic symptoms in licensed pesticide applicators in the Agricultural Health Study. Hum. Exp. Toxicol. 26, 243-250.
23. Kamel F., Tanner C., Umbach D., et al. (2007b) Pesticide exposure and self-reported Parkinson's disease in the agricultural health study. Am. J. Epidemiol. 165, 364-374.
24. Kanthasamy A. G., Kitazawa M., Kanthasamy A., and, Anantharam V., (2005) Dieldrin-induced neurotoxicity: relevance to Parkinson's disease pathogenesis. Neurotoxicology 26, 701-719.
25. Kanthasamy A. G., Kitazawa M., Yang Y., Anantharam V., and, Kanthasamy A., (2008) Environmental neurotoxin dieldrin induces apoptosis via caspase-3-dependent proteolytic activation of protein kinase C delta (PKCdelta): implications for neurodegeneration in Parkinson's disease. Mol. Brain 1, 12.
26. Kim W. G., Mohney R. P., Wilson B., Jeohn G. H., Liu B., and, Hong J. S., (2000) Regional difference in susceptibility to lipopolysaccharide-induced neurotoxicity in the rat brain: role of microglia. J. Neurosci. 20, 6309-6316.
27. Kim Y. S., Kim S. S., Cho J. J., Choi D. H., Hwang O., Shin D. H., Chun H. S., Beal M. F., and, Joh T. H., (2005) Matrix metalloproteinase-3: a novel signaling proteinase from apoptotic neuronal cells that activates microglia. J. Neurosci. 25, 3701-3711.
28. Kitazawa M., Anantharam V., and, Kanthasamy A. G., (2001) Dieldrin-induced oxidative stress and neurochemical changes contribute to apoptopic cell death in dopaminergic cells. Free Radic. Biol. Med. 31, 1473-1485.
29. Langston J. W., (2002) Parkinson's disease: current and future challenges. Neurotoxicology 23, 443-450.
30. Langston J. W., Ballard P., Tetrud J. W., and, Irwin I., (1983) Chronic parkinsonism in humans due to a product of meperidine-analog synthesis. Science 219, 979-980.
31. Lawson L. J., Perry V. H., Dri P., and, Gordon S., (1990) Heterogeneity in the distribution and morphology of microglia in the normal adult mouse brain. Neuroscience 39, 151-170.
32. Lee D. C., Womble T. A., Mason C. W., Jackson I. M., Lamango N. S., Severs W. B., and, Palm D. E., (2007) 6-Hydroxydopamine induces cystatin C-mediated cysteine protease suppression and cathepsin D activation. Neurochem. Int. 50, 607-618.
33. Levesque S., Wilson B., Gregoria V., Thorpe L. B., Dallas S., Polikov V. S., Hong J. S., and, Block M. L., (2010) Reactive microgliosis: extracellular micro-calpain and microglia-mediated dopaminergic neurotoxicity. Brain 133, 808-821.
34. Liberatore G. T., Jackson-Lewis V., Vukosavic S., Mandir A. S., Vila M., McAuliffe W. G., Dawson V. L., Dawson T. M., and, Przedborski S., (1999) Inducible nitric oxide synthase stimulates dopaminergic neurodegeneration in the MPTP model of Parkinson disease. Nat. Med. 5, 1403-1409.
35. Liu B,. (2006) Modulation of microglial pro-inflammatory and neurotoxic activity for the treatment of Parkinson's disease. AAPS J. 8, E606-621.
36. Liu B., and, Hong J. S., (2003) Role of microglia in inflammation- mediated neurodegenerative diseases: mechanisms and strategies for therapeutic intervention. J. pharmacol. exp. ther. 304, 1-7.
37. Liu B., Hassler D. F., Smith G. K., Weaver K., and, Hannun Y. A., (1998) Purification and characterization of a membrane bound neutral pH optimum magnesium-dependent and phosphatidylserine-stimulated sphingomyelinase from rat brain. J. biol. chem. 273, 34472-34479.
38. Liu B., Du L., and, Hong J. S., (2000) Naloxone protects rat dopaminergic neurons against inflammatory damage through inhibition of microglia activation and superoxide generation. J. pharmacol. exp. ther. 293, 607-617.
39. Liu B., Gao H. M., Wang J. Y., Jeohn G. H., Cooper C. L., and, Hong J. S., (2002) Role of nitric oxide in inflammation-mediated neurodegeneration. Ann. N. Y. Acad. Sci. 962, 318-331.
40. Liu B., Barber D. S., and, Stevens Jr S. M., (2012) Stable isotope labeling with amino acids in cell culture-based proteomic analysis of ethanol-induced protein expression profiles in microglia. Methods mol. biol. 829, 551-565.
41. Mao H., Fang X., Floyd K. M., Polcz J. E., Zhang P., and, Liu B., (2007) Induction of microglial reactive oxygen species production by the organochlorinated pesticide dieldrin. Brain Res. 1186, 267-274.
42. McGeer P. L., and, McGeer E. G., (2004) Inflammation and neurodegeneration in Parkinson's disease. Parkinsonism Relat. Disord. 10 (Suppl 1), S3-7.
43. Mi W., Pawlik M., Sastre M., et al. (2007) Cystatin C inhibits amyloid-beta deposition in Alzheimer's disease mouse models. Nat. Genet. 39, 1440-1442.
44. Mussap M., and, Plebani M., (2004) Biochemistry and clinical role of human cystatin C. Crit. Rev. Clin. Lab. Sci. 41, 467-550.
45. Nagai A., Ryu J. K., Terashima M., Tanigawa Y., Wakabayashi K., McLarnon J. G., Kobayashi S., Masuda J., and, Kim S. U., (2005) Neuronal cell death induced by cystatin C in vivo and in cultured human CNS neurons is inhibited with cathepsin B. Brain Res. 1066, 120-128.
46. Ochieng J., and, Chaudhuri G., (2010) Cystatin superfamily. J. Health Care Poor Underserved 21, 51-70.
47. Peng J., Stevenson F. F., Doctrow S. R., and, Andersen J. K., (2005) Superoxide dismutase/catalase mimetics are neuroprotective against selective paraquat-mediated dopaminergic neuron death in the substantial nigra: implications for Parkinson disease. J. biol. chem. 280, 29194-29198.
48. Richardson J. R., Caudle W. M., Wang M., Dean E. D., Pennell K. D., and, Miller G. W., (2006) Developmental exposure to the pesticide dieldrin alters the dopamine system and increases neurotoxicity in an animal model of Parkinson's disease. FASEB J. 20, 1695-1697.
49. Sastre M., Calero M., Pawlik M., et al. (2004) Binding of cystatin C to Alzheimer's amyloid beta inhibits in vitro amyloid fibril formation. Neurobiol. Aging 25, 1033-1043.
50. Seidler A., Hellenbrand W., Robra B. P., Vieregge P., Nischan P., Joerg J., Oertel W. H., Ulm G., and, Schneider E,. (1996) Possible environmental, occupational, and other etiologic factors for Parkinson's disease: a case-control study in Germany. Neurology, 46 1275-1284.
51. Sharma H., Zhang P., Barber D. S., and, Liu B., (2010) Organochlorine pesticides dieldrin and lindane induce cooperative toxicity in dopaminergic neurons: role of oxidative stress. Neurotoxicology 31, 215-222.
52. Stevens Jr S. M., Duncan R. S., Koulen P., and, Prokai L., (2008) Proteomic analysis of mouse brain microsomes: identification and bioinformatic characterization of endoplasmic reticulum proteins in the mammalian central nervous system. J. Proteome Res. 7, 1046-1054.
53. Sun B., Zhou Y., Halabisky B., et al. (2008) Cystatin C-cathepsin B axis regulates amyloid beta levels and associated neuronal deficits in an animal model of Alzheimer's disease. Neuron 60, 247-257.
54. Taglieri N., Koenig W., and, Kaski J. C., (2009) Cystatin C and cardiovascular risk. Clin. Chem. 55, 1932-1943.
55. Thomas B., and, Beal M. F., (2007) Parkinson's disease. Hum. Mol. Genet. 16, R183-194.
56. Tizon B., Ribe E. M., Mi W., Troy C. M., and, Levy E., (2010) Cystatin C protects neuronal cells from amyloid-beta-induced toxicity. J. Alzheimers Dis. 19, 885-894.
57. Wang T., Liu B., Zhang W., Wilson B., and, Hong J. S., (2004) Andrographolide reduces inflammation-mediated dopaminergic neurodegeneration in mesencephalic neuron-glia cultures by inhibiting microglial activation. J. pharmacol. exp. ther. 308, 975-983.
58. Zerovnik E., (2009) The emerging role of cystatins in Alzheimer's disease. BioEssays 31, 597-599.
59. Zhang P., Liu B., Jenkins G. M., Hannun Y. A., and, Obeid L. M., (1997) Expression of neutral sphingomyelinase identifies a distinct pool of sphingomyelin involved in apoptosis. J. biol. chem. 272, 9609-9612.
60. Zhang W., Wang T., Pei Z., et al. (2005) Aggregated alpha-synuclein activates microglia: a process leading to disease progression in Parkinson's disease. FASEB J. 19, 533-542.
61. Zhang P., Hatter A., and, Liu B., (2007) Manganese chloride stimulates rat microglia to release hydrogen peroxide. Toxicol. Lett. 173, 88-100.
62. Zhang P., Wong T. A., Lokuta K. M., Turner D. E., Vujisic K., and, Liu B., (2009) Microglia enhance manganese chloride-induced dopaminergic neurodegeneration: role of free radical generation. Exp. Neurol. 217, 219-230.
63. Zhang P., Lokuta K. M., Turner D. E., and, Liu B., (2010) Synergistic dopaminergic neurotoxicity of manganese and lipopolysaccharide: differential involvement of microglia and astroglia. J. Neurochem. 112, 434-443.